Concepedia

Thomas D. Southgate

TD

12

Publications

414

Citations

11

H-Index

1999

Active since

Affiliations

Cancer Research UK Manchester Institute(Current)

University of Manchester

Cancer Research UK

Cedars-Sinai Medical Center

University of California, Los Angeles

Thomas D. Southgate is an author at Cancer Research UK Manchester Institute specializing in medicine, tumor biology, and cell biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyCancer ResearchCell PhysiologyRadiation OncologyDevelopmental BiologyTumor MicroenvironmentHealth

Publications per year

1999–2010

12

Publications

12

E-Cadherin Inhibits Cell Surface Localization of the Pro-Migratory 5T4 Oncofetal Antigen in Mouse Embryonic Stem Cells

Helen Spencer, Angela M. Eastham, Catherine L.R. Merry et al. · Molecular Biology of the Cell · 2007 · 111 citations · Full text

Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors

Thomas D. Southgate, Paul A. Kingston, María G. Castro · Current Protocols in Neuroscience · 2000 · 62 citations

CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells

Thomas D. Southgate, Owen J. McGinn, Fernanda Castro et al. · PLoS ONE · 2010 · 54 citations · Full text

Cxcr4 Membrane Expression, Cell Proliferation, Cancer Biology +18

Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors

Thomas D. Southgate, Kurt M. Kroeger, Chunyan Liu et al. · Current Protocols in Neuroscience · 2008 · 34 citations · Full text

Gene Therapies, Developmental Biology, Molecular Neuroscience +15

The P140K mutant of humanO6-methylguanine-DNA-methyltransferase (MGMT) confers resistancein vitro andin vivo to temozolomide in combination with the novel MGMT inactivatorO6-(4-bromothenyl)guanine

Lorna B. Woolford, Thomas D. Southgate, Geoffrey P. Margison et al. · The Journal of Gene Medicine · 2005 · 32 citations

Chemoprevention Strategy, Methylating Agent Temozolomide, Molecular Biology +22

Rows per page

1–5 of 12